Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
1.280
+0.040 (3.23%)
May 26, 2026, 2:11 PM EDT - Market open
Onconetix Employees
Onconetix had 2 employees as of December 31, 2025. The number of employees decreased by 3 or -60.00% compared to the previous year.
Employees
2
Change (1Y)
-3
Growth (1Y)
-60.00%
Revenue / Employee
$367,599
Profits / Employee
-$5,014,918
Market Cap
88.69K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2 | -3 | -60.00% |
| Dec 31, 2024 | 5 | -7 | -58.33% |
| Dec 31, 2023 | 12 | 0 | - |
| Dec 31, 2022 | 12 | 7 | 140.00% |
| Dec 31, 2021 | 5 | - | - |
| Sep 30, 2021 | 2 | - | - |
| Jun 30, 2021 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 47 |
| Scinai Immunotherapeutics | 45 |
| Aditxt | 26 |
| Silexion Therapeutics | 14 |
| Biodexa Pharmaceuticals | 11 |
| Artelo Biosciences | 7 |
| Propanc Biopharma | 2 |
| Bone Biologics | 2 |
ONCO News
- 5 days ago - Onconetix Inc trading halted, news pending - TheFly
- 7 days ago - Onconetix announces 1-for-10 reverse stock split - TheFly
- 7 days ago - Onconetix, Inc. Announces 1-for-10 Reverse Stock Split - GlobeNewsWire
- 7 days ago - Realbotix expects transaction with Onconetix to close by October - TheFly
- 7 days ago - Realbotix Provides Update on Nasdaq Listing - Business Wire
- 13 days ago - Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study - GlobeNewsWire
- 13 days ago - Onconetix Quarterly report: Q1 2026 - Filings
- 13 days ago - Onconetix Earnings release: Q1 2026 - Filings